ARTHEMIR
LIVE

Serial Number

79364718

Owner

Arthex Biotech S.L.

Attorney

Elizabeth Lee D'Amore

Filing Date

Jan 13, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ARTHEMIR Trademark

Serial Number: 79364718 • Registration: 7349646

ARTHEMIR is a trademark filed by Arthex Biotech S.L. on January 13, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Arthex Biotech S.L. (4 trademarks)

Calle catedrático Agustín Escardino, 9

Entity Type: 99

Trademark Details

Filing Date

January 13, 2023

Registration Date

April 9, 2024

Published for Opposition

January 23, 2024

Goods & Services

Pharmaceutical products for the treatment of progressive muscle wasting disease; injectable pharmaceutical products for the treatment of progressive muscle wasting disease; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of progressive muscle wasting disease

Medical and scientific research, namely, conducting clinical trials for others; Medical and scientific research, namely, conducting clinical trials in the nature of tests for others; clinical studies for pharmaceutical products; conducting clinical trials for pharmaceutical products; scientific and medical information regarding pharmaceutical products and clinical trials; provision of information regarding results of clinical trials relating to pharmaceutical products

Filing History

FINAL DISPOSITION NOTICE SENT TO IB
Jan 2, 2025 FICS
FINAL DISPOSITION PROCESSED
Jan 2, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 19, 2024 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 9, 2024 R.PR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 9, 2024 NRCC
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 23, 2024 PUBO
NOTIFICATION PROCESSED BY IB
Jan 22, 2024 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 3, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 3, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 3, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 15, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 28, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 28, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 28, 2023 TROA
REFUSAL PROCESSED BY IB
Nov 13, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 24, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 24, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 14, 2023 RFCR
NON-FINAL ACTION WRITTEN
Oct 13, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 11, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 14, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 9, 2023 REPR